Frontlight ResearchEarly access
CompletedNo phase
Role of Home-based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis
Key facts
- Who runs it
- University of Michigan
- Where
- Ann Arbor, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 12 people enrolled
- Started
- 5 Oct 2023
- Ended
- 1 Dec 2024
- Type of study
- Interventional
- Treatments tested
- Transcutaneous Electrical Acustimulation (TEA)
- Record updated
- 4 February 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Diagnosis of chronic pancreatitis (CP), based on a score greater or equal to 4 using a previously validated Mayo scoring system that uses morphologic and functional criteria, or endosonographic features suggestive or consistent with CP based on Rosemont criteria
- Abdominal pain present at least once within the last month
- Willing and able to provide written informed consent
Who cannot take part
- Currently undergoing or about to start endoscopic therapy with Endoscopic retrograde cholangiopancreatography (ERCP) or Endoscopic ultrasound (EUS)
- Recent history of acute pancreatitis as defined by the Revised Atlanta Classification within a month prior to enrollment
- Self-reported daily use of opioids for > 12 months for weak opioids (codeine, tramadol and hydrocodone) or > 6 months for strong opioids (other opioids) in the last two years; -Self-reported ongoing illicit drug use or abuse-
- Receiving chemotherapy for cancer
- Scheduled for or with a history of pancreatic surgery (e.g. Total Pancreatectomy with Islet Auto Transplantation (TPIAT), Puestow, Frey, Whipple, other)
- Radiologic and clinical findings consistent with symptomatic pseudocyst, wall-off necrosis, infected pancreatic necrosis, or biliary obstruction within the last 6 months
- Suspected or diagnosed pancreatic cancer
- Known allergy to adhesive electrocardiogram (ECG) electrodes
- Pregnancy or breastfeeding mother
- Imprisoned individuals
- Non-English speaking patients
- Patients with bilateral below the knee amputation
- Patients with lower extremity paralysis
- Patient is participating in another clinical trial
- Patients with an implantable electrical stimulation device
Where in United States
- University of MichiganAnn Arbor, United States
About the trial
What the trial wants to find out
This research is studying a new noninvasive device-based therapy called Transcutaneous Electrical Acustimulation (TEA) to learn about its safety and how well it works as a treatment of pain in chronic pancreatitis. The purpose of this study is to investigate the potential of TEA to treat abdominal pain in patients with chronic pancreatitis (CP).
Read full original descriptionShow less
The study hypothesizes that TEA can be used as a non-pharmaceutical opioid-free approach to treat pain in chronic pancreatitis.
The group in the trial
- Transcutaneous Electrical Acustimulation (TEA)Treatment being tested
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Role of Home-based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis- A Pilot Study
- Record updated
- 4 February 2026